U.S. FDA grants breakthrough device designation for innovative EndoSound vision ultrasound system

1 September 2021 - Endosound announced today that its EndoSound Vision System received a Breakthrough Device Designation from the U.S. FDA. ...

Read more →

Amylyx Pharmaceuticals announces Health Canada accepts for review the new drug submission for AMX0035 for the treatment of ALS

31 August 2021 - Amylyx Pharmaceuticals today announced that Health Canada has accepted for review the new drug submission for AMX0035 ...

Read more →

MicroTransponder receives FDA approval for breakthrough device benefiting stroke survivors

31 August 2021 - MicroTransponder today announced US FDA premarket approval of the Vivistim Paired VNS System, which significantly improves the ...

Read more →

Jazz Pharmaceuticals announces Health Canada approval of Sunosi (solriamfetol) for excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea

31 August 2021 - Jazz Pharmaceuticals today announced the Health Canada approval and availability of Sunosi (solriamfetol) for the treatment ...

Read more →

Real world outcomes associated with new cancer medicines approved by the FDA and EMA: a retrospective cohort study

August 2021 - Real world data studies are increasingly used to support regulatory approvals, reimbursement decisions, and changes in clinical practice ...

Read more →

Teva and MedinCell announce FDA acceptance of new drug application for TV-46000/mdc-IRM as a treatment for patients with schizophrenia

31 August 2021 - File acceptance marks important milestone for Teva’s commitment to treatments for mental disorders ...

Read more →

FDA approves updated indication for Merck’s Keytruda (pembrolizumab) for treatment of certain patients with urothelial carcinoma (bladder cancer)

31 August 2021 - Keytruda approved for treatment of patients with locally advanced or metastatic urothelial carcinoma who are Not ...

Read more →

ANI Pharmaceuticals announces FDA acceptance of purified Cortrophin gel supplemental new drug application for multiple indications including multiple sclerosis, rheumatoid arthritis and nephrotic syndrome

31 August 2021 - Prescription Drug User Fee Act target action date is 29 October 2021. ...

Read more →

Zimmer Biomet and Canary Medical announce FDA de novo classification grant and authorisation to market the world's first and only smart knee implant

30 August 2021 - Post-operative gait metrics to provide real world, objective patient data. ...

Read more →

UCB announces Briviact (brivaracetam) now FDA approved to treat partial-onset seizures in paediatric patients one month of age and older

30 August 2021 - Tablets, oral solution and intravenous dosage forms of Briviact (brivaracetam) now FDA approved as both monotherapy or ...

Read more →

FDA grants breakthrough device designation for ImpediMed's SOZO digital health platform for renal failure

30 August 2021 - FDA recognises potential of SOZO digital health platform to assist clinicians in measuring exact fluid volume of ...

Read more →

Health Canada approves Myinfla (colchicine 0.5 mg extended release tablets), a new repurposed treatment for cardiovascular disease

27 August 2021 - A unique partnership between Pharmascience and the Montreal Heart Institute leads to the approval of Myinfla (colchicine ...

Read more →

FDA orphan drug approval: Octapharma’s Octagam 10% receives 7 years of market exclusivity for adult dermatomyositis

30 August 2021 - Octagam 10% expected to become the first treatment option for adults with rare immune-mediated inflammatory disease. ...

Read more →

Moderna COVID-19 vaccine gets Health Canada approval for kids 12+

27 August 2021 - As the Delta variant rages through unvaccinated populations in Canada ahead of the back-to-school season, children ...

Read more →

COVID-19 vaccine claims scheme

29 August 2021 - Medicines Australia commends the Australian Government on the COVID-19 Vaccine Claim Scheme for anyone who experiences ...

Read more →